Raymond James & Associates’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-50,288
| Closed | -$951K | – | 3919 |
|
|
2022
Q1 | $951K | Buy |
50,288
+4,351
| +9% | +$82.3K | ﹤0.01% | 2623 |
|
|
2021
Q4 | $1.61M | Buy |
45,937
+1,429
| +3% | +$50.1K | ﹤0.01% | 2314 |
|
|
2021
Q3 | $1.63M | Buy |
44,508
+4,021
| +10% | +$147K | ﹤0.01% | 2239 |
|
|
2021
Q2 | $1.59M | Buy |
40,487
+26,163
| +183% | +$1.03M | ﹤0.01% | 2259 |
|
|
2021
Q1 | $405K | Buy |
14,324
+1,293
| +10% | +$36.6K | ﹤0.01% | 3143 |
|
|
2020
Q4 | $417K | Buy |
13,031
+893
| +7% | +$28.6K | ﹤0.01% | 2913 |
|
|
2020
Q3 | $392K | Buy |
12,138
+1,191
| +11% | +$38.5K | ﹤0.01% | 2777 |
|
|
2020
Q2 | $302K | Buy |
+10,947
| New | +$302K | ﹤0.01% | 2907 |
|